Follow the Xvivo Perfusion Aktiebolag stock price and the full management transaction log of the company, a listed issuer based in Finland. Shares are listed on the FI market, under the authority of FIN-FSA. Operating in the Health Care sector, Xvivo Perfusion Aktiebolag has logged 10 insider filings. Market capitalisation: €8.1bn. The latest transaction was disclosed on 22 July 2026 (Purchase). Among the most active insiders: Gösta Johannesson. Every trade is free.
10
Insider Decl.
n/a
Thresholds
€221,676
10 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Xvivo Perfusion Aktiebolag Strong Buy (bullish), based on 5 analysts. Average price target: SEK 335.60.
35Σ signal
Buys €221,676n/a Sells
Fundamental score
Ranked 17,544 of 29,064 companies
45.7
score / 100
Value
33
Quality
59
FCF yld-1.8%
Earn yld0.3%
EV/EBITDA·
ROE4.1%
Gross mgn74%
Net mgn3.1%
Debt/EBITDA1.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.